Lanirapid and Lansoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanirapid (metildigoxin) and Lansoprazole (lansoprazole). Common drug interactions include hypoglycaemia among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Lanirapid and Lansoprazole. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.

What is Lanirapid?

Lanirapid has active ingredients of metildigoxin. eHealthMe is studying from 1,259 Lanirapid users. Check the latest studies of Lanirapid.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

97 people who take Lanirapid and Lansoprazole together, and have interactions are studied.

Lanirapid and Lansoprazole drug interactions.

What are the common drug interactions of Lanirapid and Lansoprazole, by gender? *:

female:

Hypoglycaemia (deficiency of glucose in the bloodstream)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
International normalised ratio increased
Abdominal pain upper
Arthralgia (joint pain)
Chest pain
Diarrhoea
Epistaxis (bleed from the nose)
Feeling cold
Haemorrhage (bleeding)

male:

Decreased appetite
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer)
Blast cell count increased
Blood creatine phosphokinase increased
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Dysphagia (a condition in which swallowing is difficult or painful)
Interstitial lung disease
Myalgia (muscle pain)

What are the common drug interactions of Lanirapid and Lansoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Disseminated intravascular coagulation (systemic activation of blood coagulation)
Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
Haemorrhage (bleeding)
Renal transplant
Renal tubular necrosis (death of kidney tubules)
Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
Arteriosclerosis (thickening and hardening of arteries)
Blood creatinine increased
Blood pressure decreased
Blood urea increased

50-59:

Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Coronary artery stenosis (narrowing of coronary artery)
Decreased appetite
Drug eruption (adverse drug reaction of the skin)
Dyspnoea (difficult or laboured respiration)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Electrocardiogram st segment depression
Electrocardiogram t wave inversion
Enanthema (rash formed inside the body)
Erythema (redness of the skin)

60+:

Anaemia (lack of blood)
Pneumonia
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer)
Diarrhoea
Hypophagia (reduced food intake)
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults)
International normalised ratio increased
Lung disorder (lung disease)
Nausea (feeling of having an urge to vomit)
Platelet count decreased

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 31 people, 31.96%
High Blood Pressure: 23 people, 23.71%
Cardiac Failure: 17 people, 17.53%
Diabetes: 12 people, 12.37%
Constipation: 12 people, 12.37%
Insomnia (sleeplessness): 9 people, 9.28%
Arrhythmias (irregular heartbeat): 8 people, 8.25%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 7.22%
Cardiac Failure Chronic: 7 people, 7.22%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 6.19%

* Approximation only. Some reports may have incomplete information.

Do you take Lanirapid and Lansoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously